IMAGE: The trial will be one of many to be conducted at the University of Southampton’s Centre for Cancer Immunology, which is the UK’s first and only center dedicated to cancer… view more
Credit: University of Southampton
The study, involving doctors and cancer scientists in Southampton, America and Germany, will boost the body’s immune system to kill off neuroblastoma, one of the most common childhood cancers.
The Phase 1 trial is funded by UK charities Solving Kids’ Cancer (Europe), JACK and US charities Solving Kids’ Cancer and Band of Parents. It will be one of many to be conducted at the University of Southampton’s Centre for Cancer Immunology, which is the UK’s first and only centre dedicated to cancer immunology research. The centre recently opened at University Hospital Southampton, thanks to the University’s £25m fundraising campaign.
Neuroblastoma affects around 100 children – mostly under the age of five – in the UK every year and develops from immature nerve cells. It usually starts as a tumour in the abdomen or chest, however, in many children, it spreads to other places in the body such as the bones and bone marrow.
In those cases, less than half of patients are cured despite intensive treatment which includes
Article originally posted at